As shown in Fig. 7a–c, micro-vessel density (MVD), as indicated by CD-31 staining, was significantly reduced by AS-IV treatment (p < 0.01), and VEGFA expression in tumor tissues was also reduced in the AS-IV treatment group (p < 0.01, Fig. 7a–c). Here, PECAM1 is linked to neoplasm.